Enhancement of enantioselectivity by altering alcohol concentration for esterification in supercritical CO2

Journal of Chemical Engineering of Japan

Volumn 32, Issue 3, 1999, Pages 338-340

  Wu, Jau Yann ^a   Liang, Ming Tsai ^a  

^a I SHOU UNIVERSITY   (Taiwan)

Author keywords

Cosolvent; Enantioselectivity Enhancement; Enzymatic Resolution; Substrate; Supercritical Carbon Dioxide

Indexed keywords

COSOLVENT; ENANTIOSELECTIVITY; ENZYMATIC RESOLUTION; SUPERCRITICAL CARBON DIOXIDE;

ALCOHOLS; CARBON DIOXIDE; CATALYSIS; ESTERIFICATION; SUBSTRATES; SUPERCRITICAL FLUIDS;

ENZYME KINETICS;

CHEMICAL ENGINEERING;

EID: 0032879602     PISSN: 00219592     EISSN: None     Source Type: Journal    
DOI: 10.1252/jcej.32.338     Document Type: Article

References (14)

1. Capewell, A., V. Wendel, U. Bornscheuer, H. H. Meyer and T. Scheper; "Lipase-Catalyzed Kinetic Resolution of 3-Hydroxy Esters in Organic Solvents and Supercritical Carbon Dioxide," Em. Microb. Technol., 19, 181-186 (1996)
2. Chan, A. S. C.; "A New Route to Important Chiral Drugs," CHEMTECH, 23, 46-51 (1993)
3. Chen, C.-S., Y. Fujimoto, G. Girdaukas and C. J. Sin; "Quantitative Analyses of Biochemical Kinetic Resolution of Enantiomers," J. Am. Chem. Soc., 104, 7294-7299 (1982)
4. Dobbs, J. M., J. M. Wong, K. P. Johnston and R. J. Lahicre; "Modification of SCF Phase Behavior Using Polar Cosolvents," Ind. Eng. Chem. Res., 26, 56-65 (1987)
5. Hammond, D. A., M. Karel, A. M. Klibanov and V. J. Krukonis; "Enzymatic Reactions in Supercritical Gases," Appl. Biochem. BiotechnoL, 11, 393-401 (1985)
6. Margolin, A. L.; "Enzymes in the Synthesis of Chiral Drugs," Enz. Microb. Technol., IS, 266-280 (1993)
7. Mustranta, A.; "Use of Lipases in the Resolution of Racemic Ibuprofen," Appl. Microbiol. BiotechnoL, 38, 61-66 (1992)
8. Rakels, J. L. L., P. Caillat, A. J. J. Straathof and J. J. Heijen; "Modification of the Enzyme Enantioselectivity by Product Inhibition," Biotechnol. Prog., 10, 403-409 (1994)
9. Sih, C. J.; "Process for Preparation (S) 2-Methylarylacetic Acids," European Patent Application EP 227087 (1987)
10. Tsai, S.-W. and H.-J. Wei; "Enantioselective Esterification of Racemic Naproxen by Lipases in Organic Solvent," Enz. Microb. Technol., 16, 328-333 (1994a)
11. Tsai, S.-W. and H.-J. Wei; "Effect of Solvent on Enantioselective Esterification of Naproxen by Lipase with Trimethylsilyl Methanol," BiotechnoL Bioen., 43, 64-68 (1994b)
12. Tsai, S.-W. and H.-J. Wei; "Self-Normalized Analysis of LipaseCatalyzed Conversion of Naproxen Enantiomers," J. Liq. Chromatogr., 11, 2993-3001 (1994c)
13. Tsai, S.-W., B.-Y. Liu and C.-H. Chang; "Enhancement of (S)Naproxen Ester Productivity from Racemic Naproxen by Lipase in Organic Solvents," J. Chem. Tech. Biotechnol., 65, 156-162 (1996)
14. Wu, J.-Y., "The Optical Resolution of Naproxen in Supercritical Carbon Dioxide," Report for the National Science Council, R.O.C. (NSC 85-2214-E-214-001) (1997)